BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20562737)

  • 1. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene.
    Han DH; Piao SG; Song JH; Ghee JY; Hwang HS; Choi BS; Kim J; Yang CW
    Transplantation; 2010 Jul; 90(2):135-41. PubMed ID: 20562737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
    Niemczyk M; Zegarska J; Pawłowska M; Wyzgał J; Ciszek M; Paczek L
    Transpl Immunol; 2009 Jan; 20(3):139-42. PubMed ID: 18834941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between cyclosporine-induced nephrotoxicity in reduced nephron mass and expression of kidney injury molecule-1 and aquaporin-2 gene.
    Hong ME; Hong JC; Stepkowski S; Kahan BD
    Transplant Proc; 2005 Dec; 37(10):4254-8. PubMed ID: 16387092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
    Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
    Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
    Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
    Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of N-acetylcysteine on Klotho expression and its signaling pathway in experimental model of chronic cyclosporine nephropathy in mice.
    Piao SG; Kang SH; Lim SW; Chung BH; Doh KC; Heo SB; Jin L; Li C; Yang CW
    Transplantation; 2013 Jul; 96(2):146-53. PubMed ID: 23765110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.
    Wittmann S; Daniel C; Stief A; Vogelbacher R; Amann K; Hugo C
    Transplantation; 2009 May; 87(9):1290-9. PubMed ID: 19424027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation.
    Stephany BR; Augustine JJ; Krishnamurthi V; Goldfarb DA; Flechner SM; Braun WE; Hricik DE; Dennis VW; Poggio ED
    Transplantation; 2006 Aug; 82(3):368-74. PubMed ID: 16906035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
    Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
    Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway.
    Martin-Martin N; Slattery C; McMorrow T; Ryan MP
    Am J Physiol Renal Physiol; 2011 Dec; 301(6):F1281-92. PubMed ID: 21880834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
    Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
    Transplant Proc; 2008 Oct; 40(8):2804-7. PubMed ID: 18929866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is sirolimus responsible for proteinuria?
    Dervaux T; Caillard S; Meyer C; Ellero B; Woehl-Jaegle ML; Hannedouche T; Wolf P; Moulin B
    Transplant Proc; 2005; 37(6):2828-9. PubMed ID: 16182822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension induced by immunosuppressive drugs: a comparative analysis between sirolimus and cyclosporine.
    Reis F; Parada B; Teixeira de Lemos E; Garrido P; Dias A; Piloto N; Baptista S; Sereno J; Eufrásio P; Costa E; Rocha-Pereira P; Santos-Silva A; Figueiredo A; Mota A; Teixeira F
    Transplant Proc; 2009 Apr; 41(3):868-73. PubMed ID: 19376375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
    Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF
    Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus.
    Teutonico A; Schena PF; Di Paolo S
    J Am Soc Nephrol; 2005 Oct; 16(10):3128-35. PubMed ID: 16107580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy.
    Yoon HE; Ghee JY; Piao S; Song JH; Han DH; Kim S; Ohashi N; Kobori H; Kuro-o M; Yang CW
    Nephrol Dial Transplant; 2011 Mar; 26(3):800-13. PubMed ID: 20813770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.